Initial Immune Response in Escherichia coli, Staphylococcus aureus, and Candida albicans Bacteremia
Ημερομηνία
2020Γλώσσα
en
Λέξη-κλειδί
Επιτομή
Sepsis remains a leading cause of mortality worldwide and is characterized by sustained inflammatory responses, reflected as changes in the expression profile of cytokines with time. The aim of the present study was to investigate the dynamic changes in complete blood count, serum chemistry, procalcitonin (PCT), tumor necrosis factor-alpha (TNF-α), and interleukin-6 (IL-6) in Escherichia coli, Staphylococcus aureus, and Candida albicans bacteremia. Study subjects were 32 healthy male Landrace-Large White pigs, aged 10–15 weeks and of average weight 19 ± 2 kg. Bacteremia was induced by continuous intravenous infusion of microbial suspensions during a period of 8 h. E. coli and S. aureus bacteremia were associated with a significant gradual decrease in white blood cells and platelets, respectively (p = 0.002 and p = 0.004), while candidemia was characterized by a significant gradual decrease in lymphocytes (p = 0.009). Serum PCT levels were either undetectable or very low, with no significant changes with time in all groups. E. coli bacteremia elicited a strong pro-inflammatory response, characterized by a significant increase in TNF-α expression from the onset of bacteremia (p = 0.042). C. albicans exhibited a different profile with an early, moderate increase in TNF-α followed by a subsequent marked increase in IL-6 levels (p = 0.03). The differential regulation of inflammatory and hematological responses depending on the pathogenic agent can reveal differences in the underlying inflammatory mechanisms, which may assist in the ongoing quest for the identification of a panel of circulating biomarkers during bacteremia. © 2019, Springer Science+Business Media, LLC, part of Springer Nature.
Collections
Related items
Showing items related by title, author, creator and subject.
-
Lessons from pathophysiology: Use of individualized combination treatments with immune interventional agents to tackle severe respiratory failure in patients with COVID-19
Dalekos G.N., Stefos A., Georgiadou S., Lygoura V., Michail A., Ntaios G., Samakidou A., Giannoulis G., Gabeta S., Vlychou M., Petinaki E., Leventogiannis K., Giamarellos-Bourboulis E.J., Gatselis N.K. (2021)Aims Infection by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) may lead to the development of severe respiratory failure. In hospitalized-patients, prompt interruption of the virus-driven inflammatory process ... -
Musculoskeletal infection in orthopaedic trauma: Assessment of the 2018 international consensus meeting on musculoskeletal infection
Obremskey W.T., Metsemakers W.-J., Schlatterer D.R., Tetsworth K., Egol K., Kates S., McNally M., Gibbons J., Kenny P., Stangl P., Patzakis M.J., Ferreira N., Tornetta P., III, Suda A.J., O'Hara N., Salles M.J.C., Bhashyam A.R., Morgenstern M., Manrique J., Malizos K.N., Giannoudis P., Nana A., Egol K.A., Kleftouris G., Reyes F., Klement M.R., Bautista M., Linke P., Citak M., Abdelaziz H., Ecker N.U., Suero E., Caba P., Marais L., Haasper C., Papakostidis C., Natoli R.M., Aldahamsheh O., Abuodeh Y., Quinnan S., Suarez C., Conway J.D., Sánchez Correa C.A., Leal J.A., Zalavras C., Komnos G., Shope A.J., Saxena A., Fram B., Akesson P., Haggard W.O., Vahedi H., Athanaselis E., Pesantez R., Lowenberg D.W., Gleason B., Hendershot E.F., Amaris G., Kates S.L., Chang G., Archdeacon M.T., Pinzón A., Shetty R.P., Chan J., McNally M.A., Shaffer A., Schlatterer D.R., Harris M., Matsushita K., Kvederas G., Garcia M.F., Swiontkowski M.F., Kallel S., Gutierrez V., Alt V., O'Toole R.V., Watson J.T., ICM Orthopaedic Trauma Work Group (2020)Fracture-related infections (FRIs) are among the most common complications following fracture fixation, and they have a huge economic and functional impact on patients. Because consensus guidelines with respect to prevention, ... -
ICU-Associated Gram-Negative Bloodstream Infection: Risk Factors Affecting the Outcome Following the Emergence of Colistin-Resistant Isolates in a Regional Greek Hospital
Karvouniaris M., Poulakou G., Tsiakos K., Chatzimichail M., Papamichalis P., Katsiaflaka A., Oikonomou K., Katsioulis A., Palli E., Komnos A. (2022)Intensive care unit patients may present infections by difficult-to-treat-resistant Gram-negative microorganisms. Colistin resurfaced as a last resort antibiotic for the treatment of multidrug-resistant Gram-negative ...